Across TCGA pan-cancer cohorts, HSPD1P9 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of HSPD1P9’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where HSPD1P9 RNA is repressed in tumor relative to normal tissue. In most cancer types HSPD1P9 is over-expressed in tumor, although a few such as LUSC and BRCA show the opposite, repressed pattern.

LUSC, PAAD, and BRCA are the cancer types where HSPD1P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HSPD1P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.032	.003	3	view →
PAAD	Male	All	+0.080	.015	2	view →
BRCA	All	III,IV	−0.038	.023	2	view →
KIRP	Female	All	+0.078	.029	1	view →
KICH	All	All	+0.040	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: HSPD1P9 RNA expression & survival · all HSPD1P9 data types